Devazepide

cholecystokinin ; Canis lupus familiaris







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 8661821 Cholecystokinin mediation of colonic absorption via peptide YY: foregut-hindgut axis. 1996 Feb 1
2 8769975 Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts. 1996 Feb 15 1
3 8747782 Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog. 1995 Dec 7 1
4 7910794 Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin-14 in dogs. 1994 Jun 1
5 7926458 Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs. 1994 Oct 2
6 8319843 Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs. 1993 2
7 1438992 Endogenous CCK is not involved in the regulation of interdigestive gastrointestinal and gallbladder motility in conscious dogs. 1992 Oct 13 3
8 2135899 [The role of cholecystokinin in the regulation of intestinal blood circulation and metabolism]. 1990 1
9 2437283 Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist. 1987 Apr 1
10 3441445 L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs. 1987 Nov-Dec 4